Literature DB >> 15721298

Resistance to influenza A virus infection by antigen-conjugated CpG oligonucleotides, a novel antigen-specific immunomodulator.

Mieko Hayashi1, Emi Satou, Ryouji Ueki, Mayuka Yano, Naoko Miyano-Kurosaki, Masayuki Fujii, Hiroshi Takaku.   

Abstract

Oligodeoxynucleotides (ODN) containing CpG motifs (CpG) act as modulators that bias the immune response towards a Th1-dominant phenotype. To investigate this effect further, we examined the protective effects of a covalently linked conjugate between CpG-ODN and HA-2kd antigen in mice infected with influenza A virus. The conjugated form of CpG-ODN and HA-2kd was more efficient in regulating influenza A virus than the unconjugated mixture of CpG-ODN and HA-2kd. The antigen-conjugated CpG-ODN induced an immune response with a Th1-dominant cytokine pattern characterized by the secretion of high levels of HA-2kd-specific interferon-gamma and IgG2a (Th1), which were only slightly induced by HA-2kd alone. These findings support the use of CpG-ODN-Ag conjugates as novel Ag-specific immunomodulators and suggest that CpG-ODN-HA-2kd might be a promising immune therapy for patients with influenza virus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15721298     DOI: 10.1016/j.bbrc.2005.01.116

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen.

Authors:  Rohan S Ingrole; Wenqian Tao; Jatindra N Tripathy; Harvinder S Gill
Journal:  Nano Life       Date:  2014-06-01

2.  Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza A virus.

Authors:  Wenqian Tao; Katherine S Ziemer; Harvinder S Gill
Journal:  Nanomedicine (Lond)       Date:  2013-07-05       Impact factor: 5.307

3.  Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone ® in rhesus macaques.

Authors:  Timothy D Carroll; Shannon R Matzinger; Mario Barro; Linda Fritts; Michael B McChesney; Christopher J Miller; Robert E Johnston
Journal:  Vaccine       Date:  2010-11-25       Impact factor: 3.641

4.  Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone) increases antibody response, cellular immunity, and antigenically drifted protection.

Authors:  Marla Lay; Bernadette Callejo; Stella Chang; David K Hong; David B Lewis; Timothy D Carroll; Shannon Matzinger; Linda Fritts; Christopher J Miller; John F Warner; Lily Liang; Jeffery Fairman
Journal:  Vaccine       Date:  2009-05-09       Impact factor: 3.641

5.  Broad-spectrum drugs against viral agents.

Authors:  Mary E Christopher; Jonathan P Wong
Journal:  Int J Mol Sci       Date:  2008-09-01       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.